BRIEF-Moleculin Enters Agreement With BSP Pharmaceuticals For Its Leukemia Drug Candidate

1 Min Read

April 24 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN ENTERS AGREEMENT WITH BSP PHARMACEUTICALS FOR ITS LEUKEMIA DRUG CANDIDATE

* MOLECULIN BIOTECH INC - ENGAGED BSP PHARMACEUTICALS S.P.A. TO BEGIN PREPARATIONS FOR COMMERCIAL SCALE PRODUCTION OF ANNAMYCIN DRUG PRODUCT Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below